| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
56,743 |
51,927 |
$2.42M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
23,693 |
21,199 |
$1.48M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
15,945 |
14,690 |
$957K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
14,637 |
13,467 |
$948K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
34,010 |
31,111 |
$808K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
9,388 |
8,904 |
$626K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
4,264 |
3,545 |
$417K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
26,505 |
24,685 |
$357K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
4,195 |
3,927 |
$303K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
18,810 |
17,486 |
$247K |
| 87631 |
|
1,027 |
818 |
$94K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,307 |
1,218 |
$90K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
9,293 |
8,156 |
$79K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,151 |
1,982 |
$66K |
| 92551 |
|
7,687 |
7,307 |
$59K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,999 |
1,686 |
$58K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,625 |
4,994 |
$56K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,636 |
7,317 |
$52K |
| 90474 |
|
4,656 |
4,391 |
$39K |
| 99460 |
|
943 |
854 |
$38K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
624 |
521 |
$36K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
416 |
389 |
$34K |
| 83655 |
|
4,112 |
3,459 |
$32K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
643 |
586 |
$32K |
| 87400 |
|
3,441 |
1,518 |
$30K |
| 87276 |
|
2,942 |
2,239 |
$22K |
| 87275 |
|
2,932 |
2,237 |
$21K |
| 87807 |
|
2,176 |
1,812 |
$20K |
| 0240U |
|
188 |
128 |
$18K |
| 99462 |
|
747 |
452 |
$16K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
497 |
399 |
$14K |
| 99051 |
|
694 |
652 |
$13K |
| 99173 |
|
12,348 |
11,496 |
$10K |
| 85018 |
|
4,585 |
3,936 |
$8K |
| 99215 |
Prolong outpt/office vis |
78 |
74 |
$7K |
| 99050 |
|
573 |
535 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
96 |
92 |
$6K |
| 81002 |
|
1,274 |
1,124 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
387 |
351 |
$2K |
| 0071A |
|
30 |
28 |
$1K |
| 36416 |
|
15,189 |
12,280 |
$994.17 |
| H0049 |
Alcohol and/or drug screening |
347 |
320 |
$960.00 |
| 0002A |
|
21 |
17 |
$780.69 |
| 0072A |
|
16 |
16 |
$731.12 |
| 0001A |
|
17 |
14 |
$604.28 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
60 |
57 |
$537.32 |
| 36415 |
Collection of venous blood by venipuncture |
212 |
197 |
$410.01 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
106 |
98 |
$153.24 |
| 90686 |
|
3,708 |
3,473 |
$78.72 |
| 94760 |
|
16 |
13 |
$2.19 |
| 90647 |
|
7,740 |
6,977 |
$0.05 |
| 90633 |
|
5,118 |
4,532 |
$0.04 |
| 3074F |
|
17,180 |
15,486 |
$0.00 |
| 90696 |
|
853 |
805 |
$0.00 |
| 90723 |
|
7,490 |
6,918 |
$0.00 |
| 90677 |
|
1,320 |
1,228 |
$0.00 |
| 99000 |
|
1,117 |
944 |
$0.00 |
| 90697 |
|
700 |
666 |
$0.00 |
| 90651 |
|
613 |
588 |
$0.00 |
| 90674 |
|
301 |
276 |
$0.00 |
| 91307 |
|
74 |
69 |
$0.00 |
| 90620 |
|
29 |
27 |
$0.00 |
| 3079F |
|
15 |
12 |
$0.00 |
| 90700 |
|
1,226 |
1,137 |
$0.00 |
| 90710 |
|
4,019 |
3,723 |
$0.00 |
| 90670 |
|
9,969 |
9,048 |
$0.00 |
| 90681 |
|
4,743 |
4,399 |
$0.00 |
| J7614 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
48 |
44 |
$0.00 |
| 90734 |
|
406 |
393 |
$0.00 |
| 90685 |
|
123 |
119 |
$0.00 |
| 90661 |
|
70 |
62 |
$0.00 |
| 96160 |
|
370 |
338 |
$0.00 |
| 90715 |
|
57 |
56 |
$0.00 |
| 91300 |
|
83 |
61 |
$0.00 |